Consistent with our conclusion, Lin et al. reported that inhibition of histamine receptor 3 suppressed glioblastoma invasion by inactivating the PI3K/AKT and MEK/ERK pathways in gliomas [30]. This evidence concerns the gene AKT1 and central nervous system cancer.